Our approach of considering DMRGM as a group is similar to the study by Ryotokuji et al., in which the investigators integrated four genes (IDH1/2, TET2 and DNMT3A) involving DNA methylation regulation as a group and analyzed its prognostic impact on AML. This evidence concerns the gene TET2 and acute myeloid leukemia.